Rocket


Overview
Financials
News + Filings

 
 

Incysus Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues2.40.6
            Revenue growth305.9% 
Cost of goods sold2.40.6
Gross profit0.00.0
            Gross margin0.0%0.0%
General and administrative2.71.4
EBIT-5.1-2.0
            EBIT margin-214.8%-344.9%
Pre-tax income-5.1-2.1
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-5.1-2.1
            Net margin-217.7%-358.2%
 
Diluted EPS$0.00($0.24)
Shares outstanding (diluted)8,734.78.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy